Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia

Kouji Masumoto, Kouji Nagata, Toru Uesugi, Tomomi Yamada, Tadamune Kinjo, Shunji Hikino, Toshiro Hara, Tomoaki Taguchi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: During the follow-up period in surviving patients with severe congenital diaphragmatic hernia (CDH), respiratory complications, such as recurrence of CDH or chronic lung disease, have been reported to occur as a late complication. Although some risk factors for deterioration of respiratory condition have been reported in CDH, the risk of respiratory syncytial virus (RSV) in postoperative CDH patients has not as yet been reported upon. Methods: In 21 survivors with severe CDH, which had been detected antenatally, and whose lung:thoracic ratio was <0.2, the risk of RSV infection in those patients was investigated. Results: Five survivors with severe CDH had RSV infection and three patients needed hospitalization due to bronchiolitis during the follow-up period. In two patients the recurrence of CDH after the infection resulted in the need to perform a re-operation for CDH. All patients often suffered from chronic wheezing requiring medication after the first RSV infection. Conclusion: RSV infection is a risk for deterioration of postoperative respiratory condition in severe CDH survivors. Considering the presence of pulmonary hypoplasia in severe CDH, the routine use of monoclonal antibody for RSV (palivizumab) might be effective for patients with severe CDH in the high season of RSV, similar to the patients with chronic lung disease, although further large multicenter studies are needed to clarify this hypothesis.

Original languageEnglish
Pages (from-to)459-463
Number of pages5
JournalPediatrics International
Volume50
Issue number4
DOIs
Publication statusPublished - Aug 1 2008

Fingerprint

Respiratory Syncytial Viruses
Survivors
Respiratory Syncytial Virus Infections
Lung Diseases
Congenital Diaphragmatic Hernias
Chronic Disease
Recurrence
Lung
Bronchiolitis
Respiratory Sounds
Multicenter Studies
Hospitalization
Thorax
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia. / Masumoto, Kouji; Nagata, Kouji; Uesugi, Toru; Yamada, Tomomi; Kinjo, Tadamune; Hikino, Shunji; Hara, Toshiro; Taguchi, Tomoaki.

In: Pediatrics International, Vol. 50, No. 4, 01.08.2008, p. 459-463.

Research output: Contribution to journalArticle

Masumoto, Kouji ; Nagata, Kouji ; Uesugi, Toru ; Yamada, Tomomi ; Kinjo, Tadamune ; Hikino, Shunji ; Hara, Toshiro ; Taguchi, Tomoaki. / Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia. In: Pediatrics International. 2008 ; Vol. 50, No. 4. pp. 459-463.
@article{894c43dfeec64a32b29b70addc4e7af8,
title = "Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia",
abstract = "Background: During the follow-up period in surviving patients with severe congenital diaphragmatic hernia (CDH), respiratory complications, such as recurrence of CDH or chronic lung disease, have been reported to occur as a late complication. Although some risk factors for deterioration of respiratory condition have been reported in CDH, the risk of respiratory syncytial virus (RSV) in postoperative CDH patients has not as yet been reported upon. Methods: In 21 survivors with severe CDH, which had been detected antenatally, and whose lung:thoracic ratio was <0.2, the risk of RSV infection in those patients was investigated. Results: Five survivors with severe CDH had RSV infection and three patients needed hospitalization due to bronchiolitis during the follow-up period. In two patients the recurrence of CDH after the infection resulted in the need to perform a re-operation for CDH. All patients often suffered from chronic wheezing requiring medication after the first RSV infection. Conclusion: RSV infection is a risk for deterioration of postoperative respiratory condition in severe CDH survivors. Considering the presence of pulmonary hypoplasia in severe CDH, the routine use of monoclonal antibody for RSV (palivizumab) might be effective for patients with severe CDH in the high season of RSV, similar to the patients with chronic lung disease, although further large multicenter studies are needed to clarify this hypothesis.",
author = "Kouji Masumoto and Kouji Nagata and Toru Uesugi and Tomomi Yamada and Tadamune Kinjo and Shunji Hikino and Toshiro Hara and Tomoaki Taguchi",
year = "2008",
month = "8",
day = "1",
doi = "10.1111/j.1442-200X.2008.02580.x",
language = "English",
volume = "50",
pages = "459--463",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia

AU - Masumoto, Kouji

AU - Nagata, Kouji

AU - Uesugi, Toru

AU - Yamada, Tomomi

AU - Kinjo, Tadamune

AU - Hikino, Shunji

AU - Hara, Toshiro

AU - Taguchi, Tomoaki

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Background: During the follow-up period in surviving patients with severe congenital diaphragmatic hernia (CDH), respiratory complications, such as recurrence of CDH or chronic lung disease, have been reported to occur as a late complication. Although some risk factors for deterioration of respiratory condition have been reported in CDH, the risk of respiratory syncytial virus (RSV) in postoperative CDH patients has not as yet been reported upon. Methods: In 21 survivors with severe CDH, which had been detected antenatally, and whose lung:thoracic ratio was <0.2, the risk of RSV infection in those patients was investigated. Results: Five survivors with severe CDH had RSV infection and three patients needed hospitalization due to bronchiolitis during the follow-up period. In two patients the recurrence of CDH after the infection resulted in the need to perform a re-operation for CDH. All patients often suffered from chronic wheezing requiring medication after the first RSV infection. Conclusion: RSV infection is a risk for deterioration of postoperative respiratory condition in severe CDH survivors. Considering the presence of pulmonary hypoplasia in severe CDH, the routine use of monoclonal antibody for RSV (palivizumab) might be effective for patients with severe CDH in the high season of RSV, similar to the patients with chronic lung disease, although further large multicenter studies are needed to clarify this hypothesis.

AB - Background: During the follow-up period in surviving patients with severe congenital diaphragmatic hernia (CDH), respiratory complications, such as recurrence of CDH or chronic lung disease, have been reported to occur as a late complication. Although some risk factors for deterioration of respiratory condition have been reported in CDH, the risk of respiratory syncytial virus (RSV) in postoperative CDH patients has not as yet been reported upon. Methods: In 21 survivors with severe CDH, which had been detected antenatally, and whose lung:thoracic ratio was <0.2, the risk of RSV infection in those patients was investigated. Results: Five survivors with severe CDH had RSV infection and three patients needed hospitalization due to bronchiolitis during the follow-up period. In two patients the recurrence of CDH after the infection resulted in the need to perform a re-operation for CDH. All patients often suffered from chronic wheezing requiring medication after the first RSV infection. Conclusion: RSV infection is a risk for deterioration of postoperative respiratory condition in severe CDH survivors. Considering the presence of pulmonary hypoplasia in severe CDH, the routine use of monoclonal antibody for RSV (palivizumab) might be effective for patients with severe CDH in the high season of RSV, similar to the patients with chronic lung disease, although further large multicenter studies are needed to clarify this hypothesis.

UR - http://www.scopus.com/inward/record.url?scp=50249090467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50249090467&partnerID=8YFLogxK

U2 - 10.1111/j.1442-200X.2008.02580.x

DO - 10.1111/j.1442-200X.2008.02580.x

M3 - Article

C2 - 19143967

AN - SCOPUS:50249090467

VL - 50

SP - 459

EP - 463

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 4

ER -